Euro-Tenders Login

Euro-Tenders Info

Euro-Tenders.com is an industry leading company specialized in providing information about tenders, procurements and public procurements from the European Union and South East Europe.

 

Be always ahead of the Competition. Choose a partner that you can count on. Start Making Profit Today.

Agricultural, farmin...
Petroleum products, ...
Mining, basic metals...
Food, beverages, tob...
Agricultural machine...
Clothing, footwear, ...
Leather and textile ...
Printed matter and r...
Chemical products
Office and computing...
Electrical machinery...
Radio, television, c...
Medical equipments, ...
Transport equipment ...
Security, fire-fight...
Musical instruments,...
Laboratory, optical ...
Furniture (incl. off...
Collected and purifi...
Industrial machinery
Machinery for mining...
Construction structu...
Construction work
Software package and...
Repair and maintenan...
Installation service...
Hotel, restaurant an...
Transport services (...
Supporting and auxil...
Postal and telecommu...
Public utilities
Financial and insura...
Real estate services
Architectural, const...
IT services: consult...
Research and develop...
Administration, defe...
Services related to ...
Agricultural, forest...
Business services: l...
Education and traini...
Health and social wo...
Sewage, refuse, clea...
Recreational, cultur...
Other community, soc...

EU

Austria
Belarus
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Russian Federation
Slovakia
Slovenia
Spain
Sweden
United Kingdom

SEE

Albania
Bosnia and Herzegovina
Bulgaria
Croatia
FRY Macedonia
Montenegro
Serbia
Slovenia
Prior information notice
Corrigenda
Additional information
Contract notice
Prequalifications
Request for proposal
General information
Contract awards
Other
Not applicable
Buyer profile
Public works concession
Design contest
Works contracts awarded by the concessionnair
European economic interest grouping (EEIG)
Call for expressions of interest
Periodic indicative notice (PIN) with call fo
Qualfication system with call for competition
Periodic indicative notice (PIN) without call
Qualification system without call for competi
Results of design contests
European company
Dynamic purchasing system

European News

Latest business news from Europe.

07, May 2013.

Big drug firms look to nanomedicines

Is nanomedicine the next big thing? A growing number of top drug companies seem to think so.

The ability to encapsulate potent drugs in tiny particles measuring billionths of a metre in diameter is opening up new options for super-accurate drug delivery, increasing precision hits at the site of disease with, hopefully, fewer side effects.

Three deals struck this year by privately held Bind Therapeutics, together worth nearly $1 billion if experiments are successful, highlight a new interest in using such tiny carriers to deliver drug payloads to specific locations in the body.

U.S.-based Bind is one of several biotechnology firms that are luring large pharmaceutical makers with a range of smart drug nanotechnologies, notably against cancer.

And nanomedicine is also being put to work in diagnosis, with tiny particles used to improve imaging in scanners, as well as rapidly detecting some serious infections.

In future, researchers hope to combine both treatment and diagnostics in a new approach dubbed "theranostics" that would allow doctors to monitor patients via their medicines.

After much hype but limited clinical success, scientists in the nanotechnology field finally see a turning point.

"We have been hearing about the promise of nanomedicine for a long time, but it is now really starting to move," said Dan Peer, who runs a nanomedicine laboratory at Tel Aviv University.

"There is a new level of confidence in this approach among the big pharmaceutical companies ... We will see more and more products in clinical testing over the next few years and I think that is very exciting."

Nanoparticles made of polymers, gold and even graphene - a newly-discovered form of carbon - are now in various stages of development. In cancer alone, 117 drugs are being assessed using nanoparticle formulations, though most have yet to be tried on patients, according to Thomson Reuters Pharma data.

Other potential applications include treatments for inflammatory disorders, heart and brain diseases, and pain.

Business world
Other News